CABIO Biotech established in 2004, was listed on the Shanghai Stock Exchange's STAR Market in 2019 (Stock Code: 688089). The company leverages synthetic biology as its foundational technology, with a technological platform that encompasses key modules such as strain-directed breeding, precise cellular regulation, and efficient separation and purification. Through innovative cell factory preparation methods and sustainable bio-intelligent manufacturing, CABIO provides high-quality functional ingredients, bio-based products, and innovative solutions to global customers.
Company Details
- Employees
- 23
- Founded
- -
- Address
- 高新大道, 999号,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cabio.com
- Keywords
- biotechnology, food&beverage, natural ingredients, synthetic biology, Nutrition and Health.
- HQ
- 武汉市, 湖北省
Cabio Biotech Questions
Cabio Biotech's website is http://www.cabio.com
Cabio Biotech's LinkedIn profile is https://cn.linkedin.com/company/cabio-cn
Cabio Biotech has
23 employees.
View email and phone details for 23
employees at Cabio Biotech.
Cabio Biotech's industry is
Biotechnology Research
Cabio Biotech's top competitors are
Nourish Ingredients,
Freemen Nutra Group,
Innobio Corporation Limited,
Moara Bioinsumos,
Seadragon Marine Oils Limited,
Camara Argentina De Bioinsumos (Cabio),
Biomagna Sa,
Ak Biopharm Co., Ltd.,
Biotrop Argentina,
Ecomambo.
Cabio Biotech's categories are Biotechnology Research
Cabio Biotech's founding year is 1999
